# Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery

> **NCT01755858** · PHASE1,PHASE2 · TERMINATED · sponsor: **Stealth BioTherapeutics Inc.** · enrollment: 16 (actual)

## Conditions studied

- Renal Artery Obstruction
- Hypertension, Renovascular
- Ischemia Reperfusion Injury

## Interventions

- **DRUG:** Bendavia
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01755858
- **Lead sponsor:** Stealth BioTherapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2015-12
- **Final completion:** 2016-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01755858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01755858, "Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT01755858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*